comparemela.com

Latest Breaking News On - Davidj carey - Page 1 : comparemela.com

Sentencing Law and Policy: Criminal Sentences Alternatives

Sentencing Law and Policy: Criminal Sentences Alternatives
typepad.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from typepad.com Daily Mail and Mail on Sunday newspapers.

Geisinger awarded $3 6 million to study genetics of cancer | News, Sports, Jobs

May 7, 2021 DANVILLE The National Cancer Institute (NCI), part of the National Institutes of Health, has awarded a 5-year, $3.6 million contract to Geisinger to study the role of genetic variation in cancer. Researchers from Geisinger and the NCI’s Division of Cancer Epidemiology and Genetics (DCEG) will analyze genetic data from Geisinger’s MyCode Community Health Initiative, a precision medicine project with more than 276,000 consented participants. The work will be led by David J. Carey, Ph.D., professor and chair of the Department of Molecular and Functional Genomics at Geisinger and a MyCode principal investigator, and Douglas Stewart, M.D., a senior investigator at DCEG.

Geisinger awarded $3 6 million to study genetics of cancer

Share this article Share this article DANVILLE, Pa., April 29, 2021 /PRNewswire/ The National Cancer Institute (NCI), part of the National Institutes of Health, has awarded a 5-year, $3.6 million contract to Geisinger to study the role of genetic variation in cancer. Researchers from Geisinger and the NCI s Division of Cancer Epidemiology and Genetics (DCEG) will analyze genetic data from Geisinger s MyCode Community Health Initiative, a precision medicine project with more than 276,000 consented participants. The work will be led by David J. Carey, Ph.D., professor and chair of the Department of Molecular and Functional Genomics at Geisinger and a MyCode principal investigator, and Douglas Stewart, M.D., a senior investigator at DCEG.

Geisinger wins $3 6 million contract to study the role of genetic variation in cancer

Geisinger wins $3.6 million contract to study the role of genetic variation in cancer The National Cancer Institute (NCI), part of the National Institutes of Health, has awarded a 5-year, $3.6 million contract to Geisinger to study the role of genetic variation in cancer. Researchers from Geisinger and the NCI s Division of Cancer Epidemiology and Genetics (DCEG) will analyze genetic data from Geisinger s MyCode Community Health Initiative, a precision medicine project with more than 276,000 consented participants. The work will be led by David J. Carey, Ph.D., professor and chair of the Department of Molecular and Functional Genomics at Geisinger and a MyCode principal investigator, and Douglas Stewart, M.D., a senior investigator at DCEG.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.